Cambridge’s T2 Biosystems, a developer of portable medical diagnostic products combining nanotechnology and miniaturized magnetic resonance imaging technology, today announced that John McDonough has been named its new CEO. McDonough, previously president of medical diagnostics and devices company Cytyc Development, will also join T2’s board of directors.

Bob is Xconomy's founder and chairman. You can email him at bbuderi@xconomy.com. Follow @bbuderi

• Share on Facebook
• Share on Twitter
• LinkedIn
• Email
• Reprints

Trending on Xconomy

• Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO
• Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs
• ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More